This study tests an oral chemotherapy drug (CC-486) in 11 adults with a rare type of leukemia (T-LGLL) that has returned or not responded to prior treatments. The goal is to find the best dose and see if the drug can shrink or control the cancer. Participants will take the drug b…
Phase: PHASE1, PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated May 01, 2026 15:58 UTC